(Q57607646)

6

object named as

Johannes B. Reitsma

0 references

author name string

Marinke Westerterp

1

0 references

Gerrit W. Sloof

2

0 references

Otto S. Hoekstra

3

0 references

Fiebo J. W. ten Kate

4

0 references

Gerrit A. Meijer

5

0 references

J. Jan B. van Lanschot

8

0 references

Carla F. M. Molthoff

Journal of Cancer Research and Clinical Oncology

9

0 references

publication date

25 July 2007

0 references

published in

0 references

volume

134

0 references

issue

2

0 references

page(s)

227-236

0 references

cites work

Glucose utilization of cerebral gliomas measured by [18F] fluorodeoxyglucose and positron emission tomography

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00432-007-0275-0

Prognostic value of the standardized uptake value in esophageal cancer

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00432-007-0275-0

Carbon-11 choline or FDG-PET for staging of oesophageal cancer?

21 January 2018

1 reference

12 December 2020

Fluorodeoxyglucose positron emission tomography of soft tissue tumours: is a non-invasive determination of biological activity possible?

1 reference

12 December 2020

Correlation of 18-F-fluorodeoxyglucose (FDG) accumulation with glucose transporter (Glut-1) expression in esophageal squamous cell carcinoma.

1 reference

12 December 2020

Effects of noise, image resolution, and ROI definition on the accuracy of standard uptake values: a simulation study

1 reference

12 December 2020

Impact of FDG-PET for staging of oesophageal cancer

1 reference

12 December 2020

The prognostic significance of fluorodeoxyglucose positron emission tomography imaging for patients with nonsmall cell lung carcinoma

1 reference

12 December 2020

Over-expression of facilitative glucose transporter genes in human cancer

1 reference

12 December 2020

Glucose metabolism of breast cancer assessed by 18F-FDG PET: histologic and immunohistochemical tissue analysis.

1 reference

12 December 2020

GLUT1 expression in tissue and (18)F-FDG uptake.

1 reference

12 December 2020

Systematic review of the staging performance of 18F-fluorodeoxyglucose positron emission tomography in esophageal cancer

1 reference

12 December 2020

Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma

1 reference

12 December 2020

FDG-PET prediction of head and neck squamous cell cancer outcomes

1 reference

12 December 2020

Noninvasive grading of musculoskeletal tumors using PET

1 reference

12 December 2020

Computed tomography and positron emission tomography in the pre-operative staging of oesophageal carcinoma

1 reference

12 December 2020

Diagnostic value and limitations of fluorine-18 fluorodeoxyglucose positron emission tomography for cartilaginous tumors of bone

1 reference

12 December 2020

Positron emission tomography with F-18-fluorodeoxyglucose in a combined staging strategy of esophageal cancer prevents unnecessary surgical explorations

1 reference

12 December 2020

Prognostic significance of preoperative [18-F] fluorodeoxyglucose (FDG) positron emission tomography (PET) imaging in patients with resectable soft tissue sarcomas

1 reference

12 December 2020

18F-Deoxyglucose PET for the staging of oesophageal cancer: influence of histopathological subtype and tumour grading

1 reference

12 December 2020

Metabolic imaging predicts response, survival, and recurrence in adenocarcinomas of the esophagogastric junction.

1 reference

12 December 2020

Fluorodeoxyglucose imaging: a method to assess the proliferative activity of human cancer in vivo. Comparison with DNA flow cytometry in head and neck tumors

1 reference

12 December 2020

Maximum standardized uptake values on positron emission tomography of esophageal cancer predicts stage, tumor biology, and survival.

1 reference

12 December 2020

Evaluation of distant metastases in esophageal cancer: 100 consecutive positron emission tomography scans

1 reference

12 December 2020

Predicting the prognoses of breast carcinoma patients with positron emission tomography using 2-deoxy-2-fluoro[18F]-D-glucose

1 reference

12 December 2020

Noninvasive determination of local cerebral metabolic rate of glucose in man.

1 reference

12 December 2020

Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer.

1 reference

12 December 2020

Sulindac targets nuclear beta-catenin accumulation and Wnt signalling in adenomas of patients with familial adenomatous polyposis and in human colorectal cancer cell lines

1 reference

12 December 2020

Effects of ROI definition and reconstruction method on quantitative outcome and applicability in a response monitoring trial

1 reference

12 December 2020

Glucose catabolism in cancer cells. The type II hexokinase promoter contains functionally active response elements for the tumor suppressor p53

1 reference

12 December 2020

Correlation of Glut-1 glucose transporter expression with [(18)F]FDG uptake in non-small cell lung cancer

1 reference

12 December 2020

Biological characterisation of breast cancer by means of PET.

1 reference

12 December 2020

18F-FDG uptake as a biologic prognostic factor for recurrence in patients with surgically resected non-small cell lung cancer.

1 reference

12 December 2020

Preoperative 18[F]-fluorodeoxyglucose positron emission tomography standardized uptake values predict survival after esophageal adenocarcinoma resection.

1 reference

12 December 2020

Glut-1 and hexokinase expression: relationship with 2-fluoro-2-deoxy-D-glucose uptake in A431 and T47D cells in culture

1 reference

12 December 2020

Vascular endothelial growth factor in esophageal cancer

1 reference

12 December 2020

Glucose transport and apoptosis after gene therapy with HSV thymidine kinase

1 reference

12 December 2020

Defining the priority of using 18F-FDG PET for recurrent cervical cancer

1 reference

12 December 2020

18F-FDG PET in patients with esophageal squamous cell carcinoma undergoing curative surgery: prognostic implications

1 reference

12 December 2020

Intratumoral distribution of tritiated-FDG in breast carcinoma: correlation between Glut-1 expression and FDG uptake.

1 reference

12 December 2020

Relationship between glucose transporter, hexokinase and FDG-PET in esophageal cancer.

1 reference

12 December 2020

Prognostic importance of the standardized uptake value on (18)F-fluoro-2-deoxy-glucose-positron emission tomography scan in non-small-cell lung cancer: An analysis of 125 cases. Leuven Lung Cancer Group

1 reference

12 December 2020

[18F]fluorodeoxyglucose uptake in recurrent thyroid cancer is related to hexokinase i expression in the primary tumor

1 reference

12 December 2020

Metastasis to regional lymph nodes in patients with esophageal squamous cell carcinoma: CT versus FDG PET for presurgical detection prospective study

1 reference

12 December 2020

Fluoro-deoxi-glucose uptake and angiogenesis are independent biological features in lung metastases.

1 reference

12 December 2020

Biologic correlates of (18)fluorodeoxyglucose uptake in human breast cancer measured by positron emission tomography

1 reference

12 December 2020

Association between [ 18 F]fluorodeoxyglucose uptake and postoperative histopathology, hormone receptor status, thymidine labelling index and p53 in primary breast cancer: a preliminary observation

1 reference

12 December 2020

SUV: standard uptake or silly useless value?

1 reference

12 December 2020

Relationship between retention index in dual-phase (18)F-FDG PET, and hexokinase-II and glucose transporter-1 expression in pancreatic cancer.

1 reference

12 December 2020

Does FDG uptake measure proliferative activity of human cancer cells? In vitro comparison with DNA flow cytometry and tritiated thymidine uptake.

1 reference

12 December 2020

In vivo validation of 3'deoxy-3'-[(18)F]fluorothymidine ([(18)F]FLT) as a proliferation imaging tracer in humans: correlation of [(18)F]FLT uptake by positron emission tomography with Ki-67 immunohistochemistry and flow cytometry in human lung tumor

1 reference

12 December 2020

Whole-body FDG positron emission tomographic imaging for staging esophageal cancer comparison with computed tomography.

1 reference

12 December 2020

Glucose transporters: expression, regulation and cancer.

1 reference

12 December 2020

Mammalian hexokinases and their abnormal expression in cancer

1 reference

12 December 2020

Performance evaluation of a whole-body PET scanner using the NEMA protocol. National Electrical Manufacturers Association

1 reference

12 December 2020

[(18)F]Fluorodeoxyglucose positron emission tomography and its prognostic value in lung cancer

1 reference

12 December 2020

Quantification of FDG PET studies using standardised uptake values in multi-centre trials: effects of image reconstruction, resolution and ROI definition parameters.

1 reference

12 December 2020

Recent changes in the epidemiology of esophageal cancer

1 reference

12 December 2020